A share price of Wave Life Sciences Ltd [WVE] is currently trading at $10.81, up 3.94%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WVE shares have gain 2.27% over the last week, with a monthly amount glided 1.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on February 25, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $26. Previously, Raymond James upgraded its rating to Strong Buy on October 16, 2024, and kept the price target unchanged to $22. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $11 on September 19, 2024. JP Morgan initiated its recommendation with a Overweight and recommended $10 as its price target on September 09, 2024. Wells Fargo started tracking with a Overweight rating for this stock on May 15, 2024, and assigned it a price target of $11. In a note dated December 19, 2023, Leerink Partners upgraded an Outperform rating on this stock and boosted its target price from $5 to $12.
Wave Life Sciences Ltd experienced fluctuations in its stock price throughout the past year between $4.25 and $16.74. Currently, Wall Street analysts expect the stock to reach $22.14 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $10.81 at the most recent close of the market. An investor can expect a potential return of 104.81% based on the average WVE price forecast.
Analyzing the WVE fundamentals
Trailing Twelve Months sales for Wave Life Sciences Ltd [NASDAQ:WVE] were 108.30M which represents 188.23% growth. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -1.02%, Pretax Profit Margin comes in at -0.9%, and Net Profit Margin reading is -0.9%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -1.0 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.57 points at the first support level, and at 10.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.01, and for the 2nd resistance point, it is at 11.20.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Wave Life Sciences Ltd [NASDAQ:WVE] is 2.89. Also, the Quick Ratio is 2.89, while the Cash Ratio stands at 2.72. Considering the valuation of this stock, the price to sales ratio is 15.32, the price to book ratio is 7.90.
Transactions by insiders
Recent insider trading involved BOLNO PAUL, President and CEO, that happened on Mar 07 ’25 when 0.17 million shares were sold. Officer, PAUL BOLNO completed a deal on Mar 07 ’25 to buy 0.17 million shares. Meanwhile, President and CEO BOLNO PAUL sold 50000.0 shares on Nov 25 ’24.
